Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients
Sign Up to like & getrecommendations! Published in 2022 at "Metabolites"
DOI: 10.3390/metabo12020149
Abstract: Parkinson’s disease (PD) is a progressive neurodegenerative disease, causing loss of motor and nonmotor function. Diagnosis is based on clinical symptoms that do not develop until late in the disease progression, at which point the… read more here.
Keywords: male lrrk2; metabolite signature; disease; plasma metabolite ... See more keywords